BUY Beta Drugs LimitedNuvama Wealth

⚙︎ Corp-action adjusted

byNuvama WealthHorizon: NA (inferred 1 year)16 May 2024via Institutional / Brokerage Research

Entry₹1,179.9Inferred
Target₹1,600
Total upside +35.60% (call closed)
Stop lossNot given
Exit₹1,60030 Aug 2024, 12:08 pm
Target hit+35.60%0.00%upside left

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

No assessed factors in this tip’s window yet.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.